Highly diluted antibodies to eNOS restore endothelium function in aortic rings from hypertensive rats

NV Petrova, SA Tarasov, OI Epstein… - Dose …, 2022 - journals.sagepub.com
Background Nitric oxide (NO) as a vaso-and cardio-protective agent could reduce
vasomotor dysfunction in different cardiovascular diseases. One of the current therapeutics …

Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats.

NV Petrova, SA Tarasov, OI Epstein… - Dose-response: a …, 2022 - europepmc.org
Background Nitric oxide (NO) as a vaso-and cardio-protective agent could reduce
vasomotor dysfunction in different cardiovascular diseases. One of the current therapeutics …

Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats

NV Petrova, SA Tarasov, OI Epstein… - Dose-response: a …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Nitric oxide (NO) as a vaso-and cardio-protective agent could reduce
vasomotor dysfunction in different cardiovascular diseases. One of the current therapeutics …

[引用][C] Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats

NV Petrova, SA Tarasov, OI Epstein, C Dubroca… - Dose-Response, 2022 - elibrary.ru
The authors thank employees of Сardiomedex (France) for carrying out the experiments,
using validated procedures and in accordance with the respective SOPs of the company …

Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats.

NV Petrova, SA Tarasov, OI Epstein… - Dose …, 2022 - search.ebscohost.com
Background: Nitric oxide (NO) as a vaso-and cardio-protective agent could reduce
vasomotor dysfunction in different cardiovascular diseases. One of the current therapeutics …

[HTML][HTML] Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats

NV Petrova, SA Tarasov, OI Epstein, C Dubroca… - Dose …, 2022 - ncbi.nlm.nih.gov
Background Nitric oxide (NO) as a vaso-and cardio-protective agent could reduce
vasomotor dysfunction in different cardiovascular diseases. One of the current therapeutics …